Oncology Nutrition Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Oncology Nutrition Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


The global oncology nutrition market is on track for notable growth, driven by the increasing number of cancer cases and the demand for specialized nutritional care. Progress in cancer therapies and greater awareness about the significance of nutrition in healthcare are expected to propel this market forward. Projections indicate that the oncology nutrition market will reach $2.83 billion in 2025 and grow further to $5.04 billion by 2032, achieving a CAGR of 8.60%.

Market Insights Oncology nutrition represents a critical area within the healthcare sector, focused on addressing the dietary requirements of individuals undergoing cancer treatments. Such treatments often bring challenges like malnutrition, weight loss, and reduced immune function. Personalized nutritional interventions aim to alleviate these issues, enhancing patients' quality of life and supporting therapeutic outcomes. Advances in cancer treatments like chemotherapy and immunotherapy, coupled with greater awareness of the critical role nutrition plays in patient recovery and quality of life, are driving market growth. Oncology nutrition aims to address the unique challenges faced by patients, such as malnutrition and weakened immunity, supporting better treatment outcomes and improved well-being. he oncology nutrition market is rapidly evolving to meet the growing demand for specialized dietary solutions tailored to cancer patients. With cancer rates increasing globally, the need for personalized nutritional care has never been more pressing.

Key Growth Drivers

1. Increasing Cancer Incidence: The growing prevalence of cancer worldwide underscores the need for customized nutritional solutions to improve treatment results and manage side effects.

2. Technological Progress in Cancer Care: Innovations in therapies such as chemotherapy and immunotherapy have heightened the demand for nutritional support strategies.

3. Emphasis on R&D: Research into advanced nutritional products, including targeted supplements and immune-boosting formulations, is expanding the field of oncology nutrition.

4. Rising Awareness: Both patients and healthcare professionals are increasingly recognizing the crucial role of nutrition in enhancing treatment effectiveness and overall health.

Business Opportunities

1. Adoption of Digital Health Platforms: Telehealth and mobile applications offer real-time monitoring and personalized nutritional guidance, expanding access to oncology nutrition services.

2. Innovative Product Development: Creating specialized supplements and meal replacements tailored to the unique needs of cancer patients is spurring market innovation.

3. Emerging Markets: Rapidly developing healthcare systems in South Asia and the Pacific are driving demand for oncology nutrition solutions.

Regional Analysis

1. Europe: With advanced healthcare infrastructure and a focus on comprehensive cancer care, Europe remains a leader in the oncology nutrition market.

2. South Asia and the Pacific: This region is experiencing the fastest growth due to a surge in cancer cases and increased healthcare awareness.

3. North America: Home to cutting-edge medical systems and a high incidence of cancer, North America plays a vital role in the market.

Recent Developments

1. New Product Introduction: In July 2022, Nestlé launched its first Foods for Special Medical Purposes (FSMP) in China, designed for cancer patients and approved after a rigorous five-year review process.

2. Funding Milestones: In January 2022, Faeth Therapeutics raised $47 million in a Series A funding round to support clinical trials that integrate nutrient control, pharmaceuticals, and digital tools for cancer care

Key Players Major players driving the oncology nutrition market include:
• Aceto
• B. Braun Melsungen AG
• Baxter
• Fresenius Kabi AG
• Global Health Products, Inc.
• Hormel Foods Corporation
• Mead Johnson & Company, LLC
• Meiji Holdings Co., Ltd
• Nestlé S.A.
• BioSig Technologies, Inc.
• Auris Health, Inc.

Market Segmentation The oncology nutrition market is categorized as follows:
• By Cancer Type: Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Esophageal Cancer, Lung Cancer, Breast Cancer, Blood Cancer, and Others.
• By End-use: Hospitals & Clinics, Home Care, and Others.
• By Region: North America, Europe, East Asia, South Asia & Oceania, Latin America, and the Middle East & Africa.

Please note: Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Oncology Nutrition Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Economic Overview
2.6.1. World Economic Projections
2.7. PESTLE Analysis
3. Global Oncology Nutrition Market Outlook, 2019 – 2032
3.1. Global Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 – 2032
3.1.1. Key Highlights
3.1.1.1. Head and Neck Cancers
3.1.1.2. Stomach and Gastrointestinal Cancers
3.1.1.3. Liver Cancer
3.1.1.4. Pancreatic Cancer
3.1.1.5. Esophageal Cancer
3.1.1.6. Lung Cancer
3.1.1.7. Breast Cancer
3.1.1.8. Blood Cancer
3.1.1.9. Other Cancers
3.2. Global Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 – 2032
3.2.1. Key Highlights
3.2.1.1. Hospitals & Clinics
3.2.1.2. Home Care
3.2.1.3. Others
3.3. Global Oncology Nutrition Market Outlook, by Region, Value (US$ Bn), 2019 – 2032
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Oncology Nutrition Market Outlook, 2019 – 2032
4.1. North America Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 – 2032
4.1.1. Key Highlights
4.1.1.1. Head and Neck Cancers
4.1.1.2. Stomach and Gastrointestinal Cancers
4.1.1.3. Liver Cancer
4.1.1.4. Pancreatic Cancer
4.1.1.5. Esophageal Cancer
4.1.1.6. Lung Cancer
4.1.1.7. Breast Cancer
4.1.1.8. Blood Cancer
4.1.1.9. Other Cancers
4.2. North America Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 – 2032
4.2.1. Key Highlights
4.2.1.1. Hospitals & Clinics
4.2.1.2. Home Care
4.2.1.3. Others
4.3. North America Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 – 2032
4.3.1. Key Highlights
4.3.1.1. Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
4.3.1.2. Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
4.3.1.3. Canada Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
4.3.1.4. Canada Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Oncology Nutrition Market Outlook, 2019 – 2032
5.1. Europe Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 – 2032
5.1.1. Key Highlights
5.1.1.1. Head and Neck Cancers
5.1.1.2. Stomach and Gastrointestinal Cancers
5.1.1.3. Liver Cancer
5.1.1.4. Pancreatic Cancer
5.1.1.5. Esophageal Cancer
5.1.1.6. Lung Cancer
5.1.1.7. Breast Cancer
5.1.1.8. Blood Cancer
5.1.1.9. Other Cancers
5.2. Europe Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 – 2032
5.2.1. Key Highlights
5.2.1.1. Hospitals & Clinics
5.2.1.2. Home Care
5.2.1.3. Others
5.3. Europe Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 – 2032
5.3.1. Key Highlights
5.3.1.1. Germany Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
5.3.1.2. Germany Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
5.3.1.3. U.K. Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
5.3.1.4. U.K. Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
5.3.1.5. France Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
5.3.1.6. France Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
5.3.1.7. Italy Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
5.3.1.8. Italy Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
5.3.1.9. Turkey Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
5.3.1.10. Turkey Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
5.3.1.11. Russia Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
5.3.1.12. Russia Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
5.3.1.13. Rest of Europe Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
5.3.1.14. Rest of Europe Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Oncology Nutrition Market Outlook, 2019 – 2032
6.1. Asia Pacific Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 – 2032
6.1.1. Key Highlights
6.1.1.1. Head and Neck Cancers
6.1.1.2. Stomach and Gastrointestinal Cancers
6.1.1.3. Liver Cancer
6.1.1.4. Pancreatic Cancer
6.1.1.5. Esophageal Cancer
6.1.1.6. Lung Cancer
6.1.1.7. Breast Cancer
6.1.1.8. Blood Cancer
6.1.1.9. Other Cancers
6.2. Asia Pacific Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 – 2032
6.2.1. Key Highlights
6.2.1.1. Hospitals & Clinics
6.2.1.2. Home Care
6.2.1.3. Others
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 – 2032
6.3.1. Key Highlights
6.3.1.1. China Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
6.3.1.2. China Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
6.3.1.3. Japan Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
6.3.1.4. Japan Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
6.3.1.5. South Korea Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
6.3.1.6. South Korea Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
6.3.1.7. India Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
6.3.1.8. India Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
6.3.1.9. Southeast Asia Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
6.3.1.10. Southeast Asia Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
6.3.1.11. Rest of Asia Pacific Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
6.3.1.12. Rest of Asia Pacific Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Oncology Nutrition Market Outlook, 2019 – 2032
7.1. Latin America Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 – 2032
7.1.1. Key Highlights
7.1.1.1. Head and Neck Cancers
7.1.1.2. Stomach and Gastrointestinal Cancers
7.1.1.3. Liver Cancer
7.1.1.4. Pancreatic Cancer
7.1.1.5. Esophageal Cancer
7.1.1.6. Lung Cancer
7.1.1.7. Breast Cancer
7.1.1.8. Blood Cancer
7.1.1.9. Other Cancers
7.2. Latin America Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 – 2032
7.2.1.1. Hospitals & Clinics
7.2.1.2. Home Care
7.2.1.3. Others
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 – 2032
7.3.1. Key Highlights
7.3.1.1. Brazil Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
7.3.1.2. Brazil Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
7.3.1.3. Mexico Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
7.3.1.4. Mexico Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
7.3.1.5. Argentina Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
7.3.1.6. Argentina Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
7.3.1.7. Rest of Latin America Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
7.3.1.8. Rest of Latin America Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Oncology Nutrition Market Outlook, 2019 – 2032
8.1. Middle East & Africa Oncology Nutrition Market Outlook, by Cancer Type, Value (US$ Bn), 2019 – 2032
8.1.1. Key Highlights
8.1.1.1. Head and Neck Cancers
8.1.1.2. Stomach and Gastrointestinal Cancers
8.1.1.3. Liver Cancer
8.1.1.4. Pancreatic Cancer
8.1.1.5. Esophageal Cancer
8.1.1.6. Lung Cancer
8.1.1.7. Breast Cancer
8.1.1.8. Blood Cancer
8.1.1.9. Other Cancers
8.2. Middle East & Africa Oncology Nutrition Market Outlook, by End Use, Value (US$ Bn), 2019 – 2032
8.2.1. Key Highlights
8.2.1.1. Hospitals & Clinics
8.2.1.2. Home Care
8.2.1.3. Others
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Oncology Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 – 2032
8.3.1. Key Highlights
8.3.1.1. GCC Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
8.3.1.2. GCC Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
8.3.1.3. South Africa Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
8.3.1.4. South Africa Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
8.3.1.5. Egypt Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
8.3.1.6. Egypt Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
8.3.1.7. Nigeria Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
8.3.1.8. Nigeria Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
8.3.1.9. Rest of Middle East & Africa Oncology Nutrition Market by Cancer Type, Value (US$ Bn), 2019 – 2032
8.3.1.10. Rest of Middle East & Africa Oncology Nutrition Market by End Use, Value (US$ Bn), 2019 – 2032
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2025
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1. Aceto
9.3.1.1. Company Overview
9.3.1.2. Therapy Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. B. Braun Melsungen AG
9.3.2.1. Company Overview
9.3.2.2. Therapy Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. Baxter
9.3.3.1. Company Overview
9.3.3.2. Therapy Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. Fresenius Kabi AG
9.3.4.1. Company Overview
9.3.4.2. Therapy Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. Hormel Foods Corporation
9.3.5.1. Company Overview
9.3.5.2. Therapy Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. Mead Johnson & Company, LLC
9.3.6.1. Company Overview
9.3.6.2. Therapy Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. Meiji Holdings Co., Ltd
9.3.7.1. Company Overview
9.3.7.2. Therapy Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
9.3.8. Nestlé S.A.
9.3.8.1. Company Overview
9.3.8.2. Therapy Portfolio
9.3.8.3. Financial Overview
9.3.8.4. Business Strategies and Development
9.3.9. BioSig Technologies, Inc.
9.3.9.1. Company Overview
9.3.9.2. Therapy Portfolio
9.3.9.3. Financial Overview
9.3.9.4. Business Strategies and Development
9.3.10. Auris Health, Inc.
9.3.10.1. Company Overview
9.3.10.2. Therapy Portfolio
9.3.10.3. Financial Overview
9.3.10.4. Business Strategies and Development
9.3.11. Others
9.3.11.1. Company Overview
9.3.11.2. Therapy Portfolio
9.3.11.3. Financial Overview
9.3.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings